Intravenous antiplatelet therapy may improve heart function in cardiogenic shock patients compared to oral medication
Patients who survive cardiogenic shock after a heart attack are among the highest-risk patients and have a significant risk of developing heart failure. Any improvement of heart function should reduce their risk of developing ...
Nov 9, 2026
0
6









